Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)

NCT03476070 is registered in ClinicalTrials.gov with National University of Singapore as lead sponsor.

NCT NCT03476070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03476070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)
Lead sponsor
National University of Singapore
Phase
Observational
Overall status
Unknown status
Start date
June 18, 2018
Completion date
September 1, 2022
Enrollment
236 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cognitive impairment, germ cell tumor, lymphoma